Wealth Effects LLC Oncocyte Corp Transaction History

Wealth Effects LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 02, 2023	SELL	$0.25 - $15.6 $2,625 - $163,800	-10,500 Reduced 20.59%	40,500 $12,000
Q3 2022 Nov 14, 2022	BUY	$0.76 - $15.98 $1,520 - $31,960	2,000 Added 4.08%	51,000 $37,000
Q1 2022 May 16, 2022	BUY	$1.15 - $2.25 $6,324 - $12,375	5,500 Added 12.64%	49,000 $73,000
Q4 2021 Feb 09, 2022	BUY	$2.04 - $3.59 $88,740 - $156,165	43,500 New	43,500 $94,000

411K

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $294M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

Get notified when there are updates to the investment portfolio of Wealth Effects LLC, based on Form 13F filings with the SEC.

Stay updated on Wealth Effects LLC with notifications on news.